Serengeti Asset Management LP - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 155 filers reported holding REATA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Serengeti Asset Management LP ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,509,000
-39.5%
15,000
-40.0%
0.05%
-95.2%
Q1 2021$2,493,000
-19.3%
25,0000.0%1.09%
+8.4%
Q4 2020$3,090,000
+13.3%
25,000
-10.7%
1.01%
+18.0%
Q3 2020$2,728,000
+249.7%
28,000
+460.0%
0.85%
+211.7%
Q2 2020$780,000
-64.0%
5,000
-66.7%
0.27%
-87.8%
Q1 2020$2,165,00015,0002.25%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$288,821,00055.24%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 100,000$9,970,00015.20%
Tolleson Wealth Management, Inc. 108,000$10,768,0003.25%
MADDEN SECURITIES Corp 34,787$3,468,0002.03%
Biondo Investment Advisors, LLC 101,204$10,090,0002.01%
LBJ Family Wealth Advisors, Ltd. 30,368$3,027,0001.91%
Duquesne Family Office 749,897$74,765,0001.65%
Sofinnova Investments, Inc. 238,520$23,780,0001.43%
Camber Capital Management LP 400,000$39,880,0001.37%
Integral Health Asset Management, LLC 44,000$4,387,0001.25%
View complete list of REATA PHARMACEUTICALS INC shareholders